Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 24, 2017
Source ID
10.1371/journal.ppat.1006182

Entities

People

  • Barton Haynes
  • Daniela Fera
  • David C. Montefiori
  • David Easterhoff
  • Faruk Sinangil
  • Georgia D. Tomaras
  • Guido Ferrari
  • Hao D Cheng
  • Hua-Xin Liao
  • James Tartaglia
  • Jaranit Kaewkungwal
  • Jean-Louis Excler
  • Jerome H Kim
  • Justin Pollara
  • Kevin O Saunders
  • Kevin Wiehe
  • M Anthony Moody
  • Margaret E. Ackerman
  • Merlin L Robb
  • Michael S Seaman
  • Nathan Vandergrift
  • Nelson Michael
  • Punnee Pitisuttithum
  • Rob Parks
  • Robert J. O'connell
  • S. Munir Alam
  • Sandhya Vasan
  • Sanjay Phogat
  • Sorachai Nitayaphan
  • Stephen C. Harrison
  • Supachai Rerks-ngarm
  • Thomas B. Kepler

Organizations

  • Duke University
  • Gates Foundation
  • Henry M. Jackson Foundation for the Advancement of Military Medicine
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Tags

Technology Areas

  • Biotechnology